Search Results - "Awasthi, Anshumali"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Oral Bioavailability Enhancement of Exemestane from Self-Microemulsifying Drug Delivery System (SMEDDS) by Singh, Ajeet K., Chaurasiya, Akash, Awasthi, Anshumali, Mishra, Gautam, Asati, Dinesh, Khar, Roop K., Mukherjee, Rama

    Published in AAPS PharmSciTech (2009)
    “…Limited aqueous solubility of exemestane leads to high variability in absorption after oral administration. To improve the solubility and bioavailability of…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Antidiabetic potential of polyherbal formulation DB14201: Preclinical development, safety and efficacy studies by Gopalakrishna Pillai, Geetha Krishnan, Bharate, Sonali S., Awasthi, Anshumali, Verma, Ritu, Mishra, Gautam, Singh, Anu T., Jaggi, Manu, Mithal, Ambrish, Vishwakarma, Ram A.

    Published in Journal of ethnopharmacology (02-02-2017)
    “…The poly-herbal formulation DB14201 is a new combination of ayurvedic ingredients for treatment of diabetes. The aim of present study was to investigate safety…”
    Get full text
    Journal Article
  5. 5

    Pre-clinical evidence for altered absorption and biliary excretion of irinotecan (CPT-11) in combination with quercetin: Possible contribution of P-glycoprotein by Bansal, Tripta, Awasthi, Anshumali, Jaggi, Manu, Khar, Roop K., Talegaonkar, Sushama

    Published in Life sciences (1973) (15-08-2008)
    “…P-glycoprotein (P-gp) is found to play a very significant role in intestinal and biliary transport of irinotecan and its active metabolite, SN-38. This makes…”
    Get full text
    Journal Article
  6. 6

    Preclinical pharmacokinetics and bioavailability of noscapine, a tubulin-binding anticancer agent by ANEJA, Ritu, DHIMAN, Neerupma, IDNANI, Jyoti, AWASTHI, Anshumali, ARORA, Sudershan K, CHANDRA, Ramesh, JOSHI, Harish C

    Published in Cancer chemotherapy and pharmacology (01-11-2007)
    “…Noscapine, a naturally occurring antitussive phthalideisoquinoline alkaloid, is a tubulin-binding agent currently in Phase I/II clinical trials for anticancer…”
    Get full text
    Journal Article
  7. 7

    Pharmacokinetic evaluation of C-3 modified 1,8-naphthyridine-3-carboxamide derivatives with potent anticancer activity: lead finding by Awasthi, Anshumali, Lohani, Mohtashim, Singh, Manoj K, Singh, Anu T, Jaggi, Manu

    “…To develop naphthyridine derivatives as anticancer candidates, pharmacokinetic (PK) evaluations of 10 novel derivatives of…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, Nanoxel(TM) by Madaan, Alka, Singh, Pratibha, Awasthi, Anshumali, Verma, Ritu, Singh, Anu T, Jaggi, Manu, Mishra, Shiva Kant, Kulkarni, Sadanand, Kulkarni, Hrishikesh

    Published in Clinical & translational oncology (01-01-2013)
    “…An increasing research interest has been directed toward nanoparticle-based drug delivery systems for their advantages. The appropriate amalgamation of pH…”
    Get full text
    Journal Article
  10. 10

    High performance liquid chromatography method for the pharmacokinetic study of bicalutamide SMEDDS and suspension formulations after oral administration to rats by Singh, Ajeet Kumar, Chaurasiya, Akash, Jain, Gaurav K., Awasthi, Anshumali, Asati, Dinesh, Mishra, Gautam, Khar, Roop K., Mukherjee, Rama

    Published in Talanta (Oxford) (15-06-2009)
    “…Bicalutamide is a non-steroidal antiandrogen and is an oral medication that is used for treating prostate cancer. To evaluate the bioavailability of…”
    Get full text
    Journal Article
  11. 11

    Non‐toxic melanoma therapy by a novel tubulin‐binding agent by Aneja, Ritu, Asress, Seneshaw, Dhiman, Neerupma, Awasthi, Anshumali, Rida, Padmashree C.G., Arora, Sudarshan K., Zhou, Jun, Glass, Jonathan D., Joshi, Harish C.

    Published in International journal of cancer (01-01-2010)
    “…(S)‐3‐((R)‐9‐bromo‐4‐methoxy‐6‐methyl‐5,6,7,8‐tetrahydro‐[1,3]dioxolo[4,5‐g]isoquino‐lin‐5‐yl)‐6,7‐dimethoxyisobenzofuran‐1(3H)‐one (EM011) is a…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Efficiency and mechanism of intracellular paclitaxel delivery by novel nanopolymer-based tumor-targeted delivery system, NanoxelTM by Madaan, Alka, Singh, Pratibha, Awasthi, Anshumali, Verma, Ritu, Singh, Anu T., Jaggi, Manu, Mishra, Shiva Kant, Kulkarni, Sadanand, Kulkarni, Hrishikesh

    Published in Clinical & translational oncology (2013)
    “…Introduction An increasing research interest has been directed toward nanoparticle-based drug delivery systems for their advantages. The appropriate…”
    Get full text
    Journal Article
  14. 14

    LC-UV Detection of 5′-Chloro-2,3-didehydroindolo[2′,3′:2,3]betulinic Acid in Rat Plasma and Its Application to a Pharmacokinetic Study by Mishra, Gautam, Singh, Manoj Kumar, Awasthi, Anshumali, Jaggi, Manu, Ahmad, Farhan J

    Published in Chromatographia (01-02-2011)
    “…A simple, rapid and sensitive high-performance liquid chromatography LC (HPLC) method of determining the concentration of the novel betulinic acid derivative…”
    Get full text
    Journal Article
  15. 15

    Evaluation of in vitro Anti-psoriatic Activity of a Novel Polyherbal Formulation by Multiparametric Analysis by Shraibom, Nadav, Madaan, Alka, Joshi, Vidushi, Verma, Ritu, Chaudhary, Anika, Mishra, Gautam, Awasthi, Anshumali, Singh, Anu Taneja, Jaggi, Manu

    “…We have developed a novel aqueous polyherbal formulation (SIRB-001) consisting of 3 herbs; Rheum palmatum L., Lonicera Japonica and Rehmannia glutinosa Libosch…”
    Get more information
    Journal Article